<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Johnson & Johnson]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Johnson & Johnson on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=79649"/>
<item>
<title><![CDATA[Philips to Pay $4.5 Million To Settle FCPA Allegations]]></title>
<link><![CDATA[http://www.foxbusiness.com/technology/2013/04/08/philips-to-pay-45-million-to-settle-fcpa-allegations/?]]></link>
<guid>http://www.foxbusiness.com/technology/2013/04/08/philips-to-pay-45-million-to-settle-fcpa-allegations/</guid>
<pubDate><![CDATA[Mon, 08 Apr 2013 19:15:02 EDT]]></pubDate>
<description><![CDATA[Dutch electronics giant Koninklijke Philips Electronics NV (PHG, PHIA.AE) agreed to pay U.S. regulators $4.5 million to resolve allegations of foreign bribery, a spokeswoman said.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Court reverses $482 million stent case against Cordis]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/04/court-reverses-482-million-stent-case-against-cordis/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/04/court-reverses-482-million-stent-case-against-cordis/</guid>
<pubDate><![CDATA[Thu, 04 Apr 2013 16:42:23 EDT]]></pubDate>
<description><![CDATA[Cordis Corp, a Johnson and Johnson subsidiary, did not infringe on a patent owned by a radiologist in making its Cypher stents, an appeals court said on Thursday, reversing a ruling by a lower court that ordered Cordis to pay $482 million.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Court reverses $482 million case against JNJ's Cordis]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/04/court-reverses-482-million-case-against-jnj-cordis/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/04/court-reverses-482-million-case-against-jnj-cordis/</guid>
<pubDate><![CDATA[Thu, 04 Apr 2013 13:50:53 EDT]]></pubDate>
<description><![CDATA[Cordis Corp, a Johnson and Johnson subsidiary, did not infringe upon a stent patent owned by a radiologist, an appeals court said on Thursday, reversing a ruling by a lower court which had ordered Cordis to pay $482 million.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Amgen Details Plan to Fight Patent Cliff, Lifts 2013 View]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/02/07/amgen-details-plan-to-fight-patent-cliff-lifts-2013-view/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/02/07/amgen-details-plan-to-fight-patent-cliff-lifts-2013-view/</guid>
<pubDate><![CDATA[Thu, 07 Feb 2013 15:10:14 EST]]></pubDate>
<description><![CDATA[Amgen Inc. (AMGN) said it will aggressively seek revenue over the next few years from international markets and by launching copycat drugs as the company prepares for a new phase in its history when many of its hallmark drugs lose patent protection.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[J&J shops U.S. feminine pads unit, wants to keep K-Y: sources]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/01/30/jj-shops-us-feminine-pads-unit-wants-to-keep-k-y-sources/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/01/30/jj-shops-us-feminine-pads-unit-wants-to-keep-k-y-sources/</guid>
<pubDate><![CDATA[Wed, 30 Jan 2013 13:36:45 EST]]></pubDate>
<description><![CDATA[Johnson and Johnson is looking to sell most of its U.S. feminine hygiene business, as it seeks to exit low-growth areas, but wants to keep its K-Y brand, said three people familiar with the process.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stocks Retreat From Five-year Highs]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/01/22/market-snapshot-us-stocks-retreat-from-five-year-highs/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/01/22/market-snapshot-us-stocks-retreat-from-five-year-highs/</guid>
<pubDate><![CDATA[Tue, 22 Jan 2013 11:39:28 EST]]></pubDate>
<description><![CDATA[U.S. stocks on Tuesday mostly retreated from five-year highs after home sales unexpectedly fell in December and Dow component Johnson & Johnson lowered 2013 guidance.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[MARKET SNAPSHOT: U.S. Stocks Start Near Five-year Highs]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/01/22/market-snapshot-us-stocks-start-near-five-year-highs/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/01/22/market-snapshot-us-stocks-start-near-five-year-highs/</guid>
<pubDate><![CDATA[Tue, 22 Jan 2013 09:58:48 EST]]></pubDate>
<description><![CDATA[U.S. stocks opened little changed, trading near five-year highs, on Tuesday amid corporate results that had Dow components Johnson & Johnson lowering 2013 guidance and DuPont Co. reporting profit that beat expectations.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[George Gilder: Low Tax Rates Bring More Revenue]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1967425063001/george-gilder-low-tax-rates-bring-more-revenue/?]]></link>
<guid>http://video.foxbusiness.com/v/1967425063001/george-gilder-low-tax-rates-bring-more-revenue/</guid>
<pubDate><![CDATA[Tue, 13 Nov 2012 22:12:04 EST]]></pubDate>
<description><![CDATA[Economist George Gilder on efforts to avoid the fiscal cliff and the importance of Israel to the U.S. economy.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/111312/640/360/111312_dobbs_gilder.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Is the Market Over-Reacting to the Election?]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1956660141001/is-the-market-over-reacting-to-the-election/?]]></link>
<guid>http://video.foxbusiness.com/v/1956660141001/is-the-market-over-reacting-to-the-election/</guid>
<pubDate><![CDATA[Thu, 08 Nov 2012 18:15:53 EST]]></pubDate>
<description><![CDATA[Profit Investments’ Eugene Profit and Premier Wealth/First Allied Securities Senior Wealth Strategist Mark Martiak discuss factors weighing on the markets.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/110812/640/360/110812_atb_profit.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Week Ahead: Earnings and Economic Data]]></title>
<link><![CDATA[http://www.foxbusiness.com/economy/2012/10/12/week-ahead-earnings-and-economic-data/?]]></link>
<guid>http://www.foxbusiness.com/economy/2012/10/12/week-ahead-earnings-and-economic-data/</guid>
<pubDate><![CDATA[Fri, 12 Oct 2012 16:27:00 EDT]]></pubDate>
<description><![CDATA[Third-quarter earnings season kicks into high gear next week with a slew of earnings reports from important sectors, and financial and technology bellwethers. ]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/FB/NYSE-091-Traders-on-Phone.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Bayer Backs Xarelto Sales Forecast After FDA Panel Votes Against Expanded Use]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/05/24/bayer-backs-xarelto-sales-forecast-after-fda-panel-votes-against-expanded-use/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/05/24/bayer-backs-xarelto-sales-forecast-after-fda-panel-votes-against-expanded-use/</guid>
<pubDate><![CDATA[Thu, 24 May 2012 03:58:44 EDT]]></pubDate>
<description><![CDATA[German pharmaceutical company Bayer AG (BAYN.XE) Thursday confirmed it sees peak annual sales of its Xarelto drug above EUR2 billion after a U.S. Food and Drug Administration advisory panel voted against expanded use of the blood thinner.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Gold Hits 5-Month Low]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1628534581001/gold-hits-5-month-low/?]]></link>
<guid>http://video.foxbusiness.com/v/1628534581001/gold-hits-5-month-low/</guid>
<pubDate><![CDATA[Tue, 08 May 2012 16:41:20 EDT]]></pubDate>
<description><![CDATA[FBN’s Nicole Petallides breaks down the day in the markets.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/050812/640/360/050812_market_check.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[J&J Fined $1 Billion over Risperdal]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1558800817001/jj-fined-1-billion-over-risperdal/?]]></link>
<guid>http://video.foxbusiness.com/v/1558800817001/jj-fined-1-billion-over-risperdal/</guid>
<pubDate><![CDATA[Thu, 12 Apr 2012 11:33:12 EDT]]></pubDate>
<description><![CDATA[Attorney Mark Lanier on the upcoming case against the pharmaceutical giant.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/041212/640/360/041212_Varney_Lanier.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[CEOs Getting Too Many Bonuses, Allowances Despite Poor Performance?]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1510979758001/ceos-getting-too-many-bonuses-allowances-despite-poor-performance/?]]></link>
<guid>http://video.foxbusiness.com/v/1510979758001/ceos-getting-too-many-bonuses-allowances-despite-poor-performance/</guid>
<pubDate><![CDATA[Thu, 15 Mar 2012 19:24:11 EDT]]></pubDate>
<description><![CDATA[“Red Eye” Ombudsman Andy Levy on the big bonuses and allowances given to CEOs.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/031512/640/360/031512_willis_levy.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Dow Finally Closes Above 13K]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1479392252001/dow-finally-closes-above-13k/?]]></link>
<guid>http://video.foxbusiness.com/v/1479392252001/dow-finally-closes-above-13k/</guid>
<pubDate><![CDATA[Tue, 28 Feb 2012 19:00:57 EST]]></pubDate>
<description><![CDATA[FBN’s Nicole Petallides on the winning stocks that helped boost the Dow above the 13,000 milestone.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/022812/640/360/022812_cavuto_petallides.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Johnson & Johnson CEO to Step Down]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1466693449001/johnson--johnson-ceo-to-step-down/?]]></link>
<guid>http://video.foxbusiness.com/v/1466693449001/johnson--johnson-ceo-to-step-down/</guid>
<pubDate><![CDATA[Wed, 22 Feb 2012 15:15:37 EST]]></pubDate>
<description><![CDATA[FBN’s Ashley Webster on Johnson & Johnson CEO William Weldon’s plans to step down in April.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/022212/640/360/022212_fbb_brief245.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Ralph Nader on Cutting Corporate Welfare, Taxing the Rich]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1453004351001/ralph-nader-on-cutting-corporate-welfare-taxing-the-rich/?]]></link>
<guid>http://video.foxbusiness.com/v/1453004351001/ralph-nader-on-cutting-corporate-welfare-taxing-the-rich/</guid>
<pubDate><![CDATA[Tue, 14 Feb 2012 18:37:40 EST]]></pubDate>
<description><![CDATA[“Only the Super-Rich Can Save Us” author Ralph Nader on cutting corporate welfare and why companies should give more back to their shareholders.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/021412/640/360/021412_atb_nader.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Jessica Alba Enters the Baby-Products Game]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1452511686001/jessica-alba-enters-the-baby-products-game/?]]></link>
<guid>http://video.foxbusiness.com/v/1452511686001/jessica-alba-enters-the-baby-products-game/</guid>
<pubDate><![CDATA[Tue, 14 Feb 2012 11:50:01 EST]]></pubDate>
<description><![CDATA[Actress Jessica Alba on her Honest Company and her push for baby-safe products.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/021412/640/360/021412_Varney_Alba.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Investment Strategies for 2012]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1349192230001/investment-strategies-for-2012/?]]></link>
<guid>http://video.foxbusiness.com/v/1349192230001/investment-strategies-for-2012/</guid>
<pubDate><![CDATA[Tue, 27 Dec 2011 15:01:55 EST]]></pubDate>
<description><![CDATA[Haverford Trust V.P. Hank Smith on the outlook for the markets and how investors should adjust their portfolio for the year ahead.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/122711/640/360/122711_fb_smith.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Market Outlook: Will 2012 Flatline?]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/1338351822001/market-outlook-will-2012-flatline/?]]></link>
<guid>http://video.foxbusiness.com/v/1338351822001/market-outlook-will-2012-flatline/</guid>
<pubDate><![CDATA[Tue, 20 Dec 2011 18:08:38 EST]]></pubDate>
<description><![CDATA[Will the market have better values going forward?]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/122011/640/360/122011_dotcom_MARKETS.jpg</media:thumbnail>
</item>
</channel>
</rss>
